KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Accured Expenses (2016 - 2026)

Supernus Pharmaceuticals has reported Change in Accured Expenses over the past 15 years, most recently at -$40.3 million for Q4 2025.

  • Quarterly Change in Accured Expenses fell 35.01% to -$40.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.6 million through Dec 2025, down 63.61% year-over-year, with the annual reading at -$24.6 million for FY2025, 63.61% down from the prior year.
  • Change in Accured Expenses was -$40.3 million for Q4 2025 at Supernus Pharmaceuticals, down from $18.3 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $44.9 million in Q2 2021 and troughed at -$63.1 million in Q3 2021.
  • The 5-year median for Change in Accured Expenses is $3.2 million (2021), against an average of -$1.9 million.
  • Year-over-year, Change in Accured Expenses plummeted 2183.25% in 2021 and then skyrocketed 405.27% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $33.9 million in 2021, then crashed by 119.18% to -$6.5 million in 2022, then dropped by 26.06% to -$8.2 million in 2023, then plummeted by 264.25% to -$29.9 million in 2024, then tumbled by 35.01% to -$40.3 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Change in Accured Expenses are -$40.3 million (Q4 2025), $18.3 million (Q3 2025), and -$6.5 million (Q2 2025).